Literature DB >> 23671282

DEF pocket in p38α facilitates substrate selectivity and mediates autophosphorylation.

Netanel Tzarum1, Nadav Komornik, Dorin Ben Chetrit, David Engelberg, Oded Livnah.   

Abstract

Signaling processes are primarily promoted by molecular recognition and corresponding protein-protein interactions. One of the key eukaryotic signaling pathways is the MAP kinase cascade involved in vital cellular processes such as cell proliferation, differentiation, apoptosis, and stress response. The principle recognition site of MAP kinases, the common docking (CD) region, forms selective interactions with substrates, upstream activators, and phosphatases. A second docking site, defined as the DEF site interaction pocket (DEF pocket), is formed subsequent to ERK2 and p38α activation. Both crystal structures of p38α in its dually phosphorylated form and of intrinsically active mutants showed the DEF pocket, giving motivation for studying its role in substrate activation and selectivity. Mutating selected DEF pocket residues significantly decreased the phosphorylation levels of three p38α substrates (ATFII, Elk-1, and MBP) with no apparent effect on the phosphorylation of MK2 kinase. Conversely, mutating the CD region gave the opposite effect, suggesting p38α substrates can be classified into DEF-dependent and DEF-independent substrates. In addition, mutating DEF pocket residues decreased the autophosphorylation capability of intrinsically active p38α mutants, suggesting DEF-mediated trans-autophosphorylation in p38α. These results could contribute to understanding substrate selectivity of p38α and serve as a platform for designing p38α-selective DEF site blockers, which partially inhibit p38α binding DEF-dependent substrates, whereas maintaining its other functions intact. In this context, preliminary results using synthetic peptides reveal significant inhibition of substrate phosphorylation by activated p38α.

Entities:  

Keywords:  Autophosphorylation; Docking Region; MAP Kinase; MAP Kinases (MAPKs); Molecular Docking; Protein Phosphorylation; Substrate Selectivity; Threonine-serine Protein Kinase; p38

Mesh:

Substances:

Year:  2013        PMID: 23671282      PMCID: PMC3707655          DOI: 10.1074/jbc.M113.464511

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  44 in total

1.  A conserved docking site in MEKs mediates high-affinity binding to MAP kinases and cooperates with a scaffold protein to enhance signal transmission.

Authors:  A J Bardwell; L J Flatauer; K Matsukuma; J Thorner; L Bardwell
Journal:  J Biol Chem       Date:  2000-12-28       Impact factor: 5.157

2.  MAPKK-independent activation of p38alpha mediated by TAB1-dependent autophosphorylation of p38alpha.

Authors:  Baoxue Ge; Hermann Gram; Franco Di Padova; Betty Huang; Liguo New; Richard J Ulevitch; Ying Luo; Jiahuai Han
Journal:  Science       Date:  2002-02-15       Impact factor: 47.728

Review 3.  Oncogenic kinase signalling.

Authors:  P Blume-Jensen; T Hunter
Journal:  Nature       Date:  2001-05-17       Impact factor: 49.962

4.  Selective targeting of MAPKs to the ETS domain transcription factor SAP-1.

Authors:  A Galanis; S H Yang; A D Sharrocks
Journal:  J Biol Chem       Date:  2001-01-12       Impact factor: 5.157

5.  A conserved docking motif in MAP kinases common to substrates, activators and regulators.

Authors:  T Tanoue; M Adachi; T Moriguchi; E Nishida
Journal:  Nat Cell Biol       Date:  2000-02       Impact factor: 28.824

6.  Crystal structures of MAP kinase p38 complexed to the docking sites on its nuclear substrate MEF2A and activator MKK3b.

Authors:  Chung I Chang; Bing-e Xu; Radha Akella; Melanie H Cobb; Elizabeth J Goldsmith
Journal:  Mol Cell       Date:  2002-06       Impact factor: 17.970

7.  Isolation of hyperactive mutants of the MAPK p38/Hog1 that are independent of MAPK kinase activation.

Authors:  M Bell; R Capone; I Pashtan; A Levitzki; D Engelberg
Journal:  J Biol Chem       Date:  2001-04-17       Impact factor: 5.157

Review 8.  AP-1 in cell proliferation and survival.

Authors:  E Shaulian; M Karin
Journal:  Oncogene       Date:  2001-04-30       Impact factor: 9.867

9.  Molecular determinants that mediate selective activation of p38 MAP kinase isoforms.

Authors:  H Enslen; D M Brancho; R J Davis
Journal:  EMBO J       Date:  2000-03-15       Impact factor: 11.598

10.  Molecular interpretation of ERK signal duration by immediate early gene products.

Authors:  Leon O Murphy; Sallie Smith; Rey-Huei Chen; Diane C Fingar; John Blenis
Journal:  Nat Cell Biol       Date:  2002-08       Impact factor: 28.824

View more
  12 in total

1.  Discovery and Characterization of a Biologically Active Non-ATP-Competitive p38 MAP Kinase Inhibitor.

Authors:  Brice A P Wilson; Muhammad S Alam; Tad Guszczynski; Michal Jakob; Shilpa R Shenoy; Carter A Mitchell; Ekaterina I Goncharova; Jason R Evans; Peter Wipf; Gang Liu; Jonathan D Ashwell; Barry R O'Keefe
Journal:  J Biomol Screen       Date:  2015-11-04

Review 2.  Ten things you should know about protein kinases: IUPHAR Review 14.

Authors:  Doriano Fabbro; Sandra W Cowan-Jacob; Henrik Moebitz
Journal:  Br J Pharmacol       Date:  2015-03-24       Impact factor: 8.739

3.  Types and effects of protein variations.

Authors:  Mauno Vihinen
Journal:  Hum Genet       Date:  2015-01-24       Impact factor: 4.132

4.  The bacterial metalloprotease NleD selectively cleaves mitogen-activated protein kinases that have high flexibility in their activation loop.

Authors:  Lihi Gur-Arie; Maayan Eitan-Wexler; Nina Weinberger; Ilan Rosenshine; Oded Livnah
Journal:  J Biol Chem       Date:  2020-05-13       Impact factor: 5.157

5.  Novel Noncatalytic Substrate-Selective p38α-Specific MAPK Inhibitors with Endothelial-Stabilizing and Anti-Inflammatory Activity.

Authors:  Nirav G Shah; Mohan E Tulapurkar; Aparna Ramarathnam; Amanda Brophy; Ramon Martinez; Kellie Hom; Theresa Hodges; Ramin Samadani; Ishwar S Singh; Alexander D MacKerell; Paul Shapiro; Jeffrey D Hasday
Journal:  J Immunol       Date:  2017-03-15       Impact factor: 5.422

6.  Small-molecule inhibitors of ERK-mediated immediate early gene expression and proliferation of melanoma cells expressing mutated BRaf.

Authors:  Ramin Samadani; Jun Zhang; Amanda Brophy; Taiji Oashi; U Deva Priyakumar; E Prabhu Raman; Franz J St John; Kwan-Young Jung; Steven Fletcher; Edwin Pozharski; Alexander D MacKerell; Paul Shapiro
Journal:  Biochem J       Date:  2015-05-01       Impact factor: 3.857

Review 7.  Kinase Atlas: Druggability Analysis of Potential Allosteric Sites in Kinases.

Authors:  Christine Yueh; Justin Rettenmaier; Bing Xia; David R Hall; Andrey Alekseenko; Kathryn A Porter; Krister Barkovich; Gyorgy Keseru; Adrian Whitty; James A Wells; Sandor Vajda; Dima Kozakov
Journal:  J Med Chem       Date:  2019-07-05       Impact factor: 7.446

8.  A temperature-dependent conformational shift in p38α MAPK substrate-binding region associated with changes in substrate phosphorylation profile.

Authors:  Daniel Deredge; Patrick L Wintrode; Mohan E Tulapurkar; Ashish Nagarsekar; Yinghua Zhang; David J Weber; Paul Shapiro; Jeffrey D Hasday
Journal:  J Biol Chem       Date:  2019-06-18       Impact factor: 5.157

9.  GATA Factor-Dependent Positive-Feedback Circuit in Acute Myeloid Leukemia Cells.

Authors:  Koichi R Katsumura; Irene M Ong; Andrew W DeVilbiss; Rajendran Sanalkumar; Emery H Bresnick
Journal:  Cell Rep       Date:  2016-08-18       Impact factor: 9.423

10.  Computational Analysis of Crystallization Additives for the Identification of New Allosteric Sites.

Authors:  Jade Fogha; Julien Diharce; Alan Obled; Samia Aci-Sèche; Pascal Bonnet
Journal:  ACS Omega       Date:  2020-02-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.